Enrolling

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ADorable-1)

J2T-MC-KGBI -

The main purpose of this study is to measure the effect, safety and how well the body absorbs Lebrikizumab in pediatric participants 6 months to <18 years of age with moderate-to-severe atopic dermatitis (AD).

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
6 months - 17 years
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
Lebrikizumab, Topical corticosteroid
Could I receive a Placebo?
Yes
Enrollment Goal
300
Trial Dates
Oct 18, 2022 - Jun 2025
How long will I be in the trial?
The study will last about 30 weeks and may include up to 12 visits.
Trial Phase
III

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have Atopic Dermatitis for at least 6 months if younger than 6 years old or 1 year if older than 6 years

  • 6 months to 12 years old and weigh over 6 kilograms

  • 12 to 18 years old and weigh less than 40 kilograms

  • A parent or legal guardian must be able to sign the consent document and follow to the guidelines of the study

  • And meet other additional conditions at the time of the first visit

Participants Must Not:

  • Have been in a similar study with a similar drug or received a forbidden treatment within the last 2 - 8 weeks

  • Be pregnant or breastfeeding

  • Have had previous reaction to the study drug or the ointments or cremes used in this study

  • Have a severe or current infection that requires strong antibiotics

  • Have a history of or have a current disease, or type of illness that your doctor believes could affect your safety

  • Have an addiction to drugs or alcohol

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Take the Next Step

Complete this Lilly Trial Connect questionnaire to find out if this clinical trial may be a good fit for you, or a loved one.
When you press Start Lilly Trial Connect, you will answer questions about relevant medical conditions and treatment history. The answers will be compared to some of the key criteria for this trial, called inclusion and exclusion criteria.

If your responses show that the trial may be a good fit, you can:
  • Select which clinical trial site works best for you.
  • Share your details and questionnaire directly with site(s) that allow this.
  • Get contact details for the site(s) of your choice.

Completing the Trial Connect questionnaire doesn’t mean that you will be enrolled in a study. There may be more eligibility criteria for the study which are assessed by the Lilly clinical team.

Clinical Trial Resources